Molly(R) 2.25 Modular Platform Autoinjector

Molly(R) 2.25 Modular Platform Autoinjector

Products
Molly(R) 2.25 Modular Platform Autoinjector
Molly(R) 2.25 Modular Platform Autoinjector

Information

Molly(R) 2.25 is a large-volume variant of the Molly autoinjector, developed to support the delivery of larger-volume biologics with the same 2-step operation. Built on a modular platform, Molly 2.25 enables high-volume manufacturing, faster development, and flexible design for unique branding needs. Molly 2.25 can be configured with a pre-filled syringe (PFS) featuring an 8 mm or ½ inch needle, offering flexibility to support diverse drug delivery requirements.
All Categories
InjectablesMedical Devices and Medical PackagingContract ManufacturingInjectable systems and componentsHigh viscosity drug delivery device
Main Categories
Finished Dosage Forms (Products)Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Packaging Materials and Equipment (Products)Drug Delivery Devices & Systems (Products)
Distribution Areas
North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesSouth America (e.g. Brazil, Colombia)
SHL Medical AGSHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Headquartered in Switzerland with sites across three continents, we offer end-to-end services, from design and development to final assembly, labeling, and packaging, partnering with pharma companies to deliver self-injection systems that enable patients' independence.

Log in

See all the content and easy-to-use features by logging in or registering!